How innovation, advanced manufacturing, and expertise drive success in the evolving CDMO and generics landscape.

“Having a cutting-edge facility dedicated to developing and manufacturing sterile drug products, including to a commercial scale, strengthens our ability to offer comprehensive end-to-end ...

We assessed the best available evidence of non-drug and non-surgical treatments to alleviate low back pain. Our review—published today by the independent, international group the Cochrane ...

The integration of AI and cloud technologies is transforming pharmaceutical manufacturing regulations, focusing on safety, efficiency, and global harmonization.

Researchers at the University of Missouri have developed an innovative electrochemistry method to create new molecules using ...

Artificial intelligence has already made its mark in commercial industries, and there's a good argument to be made that AI is most impactful in the drug discovery marketplace: Drug discovery ...

Continuous manufacturing could be the solution. Unlike batch manufacturing, where drug production is segmented into a series of slow-moving steps, continuous manufacturing relies on a fully ...

In parenteral sterile fill-finish manufacturing, drug products must be free from viable microorganisms – critical for products administered via injection or other routes where sterility is paramount.

The phase 2a trial showed rapid onset as well as long-lasting pain reduction with Algiax's allosteric GABAA-receptor modulator AP-325, setting up further trials of the drug. Neuropathic pain can ...

“Having a cutting-edge facility dedicated to developing and manufacturing sterile drug products, including to a commercial scale, strengthens our ability to offer comprehensive end-to-end services, ...

Statins are one commonly prescribed medication for controlling cholesterol, but these drugs might not be right for everyone. There are several treatment options for high cholesterol, including ...

Manufacturing Regulations ... actions taken against non-compliant manufacturers, additional measures planned to strengthen enforcement mechanisms. Alarming Data on Spurious and Substandard Drugs The ...